期刊文献+

荧光原位杂交技术检测肺癌患者痰液中部分染色体数量的改变 被引量:2

Detection of chromosome number abnormalities by fluorescence in situ hybridization in sputum samples from patients with lung cancer
下载PDF
导出
摘要 目的应用染色体特异性探针对痰液脱落细胞进行荧光原位杂交(fluorescence in situ hybridization,FISH)用以分析肺癌的染色体畸变,探讨FISH技术辅助诊断肺癌的可行性和有效性。方法选用3、7、17号染色体着丝粒探针,p16、p53探针对40例疑似肺癌患者痰液的脱落细胞进行FISH研究。结果肺癌患者痰液脱落细胞中3、7、17号染色体数目和p16、p53畸变阳性率分别为41.9%、45.2%、41.9%、54.9%、51.6%,其中p16、p53畸变率较高。FISH联合应用五种探针诊断肺癌的敏感性为80.6%,特异性为77.8%,诊断效率为80.0%。结论肺癌的发生、发展与染色体的畸变有关,应用FISH技术检测肺癌患者痰液细胞染色体数目畸变,可作为肺癌诊断的一项辅助方法。 Purpose To study the molecular cytogenetic alterations of the lung cancer with exfoliated cells in sputum samples by Fluo- rescence in situ Hybridization (FISH) analysis of chromosome-specific probes, and evaluate the possibility and validity of FISH in de- tecting of the lung cancer. Methods FISH was performed using 3, 7, 17 and p16, p53 of chromosome-specific probes to examine chromosome aberration of exfoliated cells in 40 sputum samples from patients suspected of having lung cancer. Results The frequency of numerical aberration of chromosomes 3,7, 17 and p16, p53 was 41.9% , 45.2% , 4l. 9%, 54. 9% and 51.6% in sputum exfolia- ted cells. Loss of chromosome p16, p53 was the most common finding. As using the 5 chromosome probes in combination for detecting lung cancer, the sensitivity was 80.6%, the specificity was 77.8%, diagnostic concordance rate was 80. 0%. Conclusions A number of chromosome aberrations are detected in the lung cancer by FISH technique which provides a basis for further understanding of its molecular pathogenesis, and can be used as an adjunctive tool for the diagnosis, prognosis of lung cancer.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第5期539-542,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 新疆维吾尔自治区教育厅青年教师科研培养基金(XJEDU2009S54)
关键词 肺肿瘤 荧光原位杂交 痰脱落细胞 lung neoplasms fluorescence in situ hybridization exfoliated cell
  • 相关文献

参考文献12

  • 1母新华,陈照丽,赫捷.肺癌多阶段发病过程中的分子机制简述[J].中国肺癌杂志,2006,9(2):211-214. 被引量:3
  • 2Jett J R,Midthun D E.Screening for lung cancer:current status and future directions:Thomas A.Neff lecture[J].Chest,2004,125(5S):158-62.
  • 3Bechtel J J,Kelley W R,Petty T L,et al.Outcome of 51 patients with roentgenographically occult lung cancer detected by sputum cytologic testing:a community hospital program[J].Arch Intern Med,1994,154(14):1582.
  • 4刘梦海,梁忠泉,袁昌隆,李伯祥.痰液和胸腹水沉积物切片在肿瘤脱落细胞学中的作用[J].临床与实验病理学杂志,2003,19(4):409-412. 被引量:16
  • 5Takahashi T,Nau M M,Chiba I,et al.p53:a frequent target for genetic abnormalities in lung cancer[J].Science,1989,246:491-4.
  • 6Gazzeri S,Gouyer V,Vour'ch C,et al.Mechanisms of p16INK4a inactivation in non small-cell lung cancers[J].Oncogene,1998,16(4):497-504.
  • 7Jin Y,Mandahl N,Heim S,et al.Isochromosomes i(8q) or i(9q) in three adenocarcinomas of the lung[J].Cancer Genet Cytogenet,1988,33(1):11-7.
  • 8Fan Y S,Li P.Cytog eneic studies of four human lung adenocarcinomas cell lines[J].Cancer Genet Cytogenet,1987,26(2):317-25.
  • 9Lee J,Pathak S,Hopwood V,et al.Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue[J].Cancer Res,1987,47(23):6349-52.
  • 10包国良,冯久贤,董强刚,沙慧芳,江晓丰,黄进肃,廖美琳.非小细胞肺癌不同组织标本中P16基因的PCR-SSCP分析[J].临床肿瘤学杂志,2002,7(1):1-4. 被引量:2

二级参考文献54

  • 1田辉,王善政,张振国,张廷国,刘文君.原发性肺癌bcl-2和p16蛋白表达与肿瘤临床病理学特征及预后的关系[J].临床肿瘤学杂志,1997,2(2):18-22. 被引量:8
  • 2Lippman SM, Spitz MR. Lung cancer chem-oprevention: an integrated approach.J Clin Oncol,2001,19( 18 Suppl):74S-82S.
  • 3Tran Y, Benbatoul K, Gorse K, et al. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene, 1998, 17 (26):3499-3505.
  • 4Shiseki M, Kohno T, Adachi J, et al.Comparative allelotype of early and advanced stage non-small cell lung carcinomas. Genes Chromosomes Cancer, 1996.17(2):71-77.
  • 5Kawanishi M, Kohno T, Otsuka T, et al.Allelotype and replication error phenotype of small cell lung carcinoma. Carcinogenesis,1997,18(11):2057-2062.
  • 6Virmani AK, Fong KM, Kodagoda D, et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer, 1998,21(4) : 308-319.
  • 7Shiseki M, Kohno T, Nishikawa R, et al.Frequent allelic losses on chromosomes 2q,18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res, 1994. 54(21) : 5643-5648.
  • 8Kohno T, Kawanishi M, Matsuda S, et al.Homozygous deletion and frequent allelic loss of the 21q11.1-q21. 1 region including the ANA gene in human lung carcinoma.Genes Chromosomes Cancer, 1998,21(3) :236-243.
  • 9Tsuchiya E, Nakamura Y, Weng SY. et al. Allelotype of non-small cell lung carcinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res. 1992, 52(9) : 2478-2481.
  • 10Sato S, Nakamura Y, Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.Cancer Res,1994,54(21) : 5652-5655.

共引文献22

同被引文献9

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部